Choose the form that best suits your needs
Lower risk of major cardiovascular events Clinical trials have shown that GLP-1 receptor agonists significantly reduce the risk of heart attack, stroke, and cardiovascular-related death in people with type 2 diabetes
These peptides show promising results in research on how the body regulates skin color through melanocortin receptor signaling and related biological responses
Januvia belongs to a class of medications called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors), while Mounjaro is a dual GIP/GLP-1 receptor agonist
Avoiding or limiting the consumption of animal products is a central tenet of plant-based diets. In contrast, a focus on whole plant foods, including fruits, vegetables, nuts, legumes, and grains, is advocated
Medication Storage Matters Too Injectable GLP-1 medications often need specific storage conditions